COLORADO SPRINGS, CO (PRWEB) September 20, 2016
Pyxant Labs Inc., a privately held bioanalytical laboratory, today announced that its Clinical Laboratory Services (CLS) business unit is now operational and accepting clinical samples. Pyxant Labs CLS division assays patient specimens, including urine, oral fluids and blood, for prescribing physicians, clinics, and hospitals, supporting superior patient outcomes through medication management and clinical diagnostics.
“The experience Pyxant Labs has gained in the past 16 years serving the highly stringent pharmaceutical industry has been instrumental in building a best-in-class CLS unit. From the onset, Pyxant CLS has one the most qualified and efficient LC/MS/MS method development teams in the entire industry. Furthermore, the extensive experience Pyxant Labs has gained working in the highly regulated drug development environment, which includes five FDA and numerous pharma companies inspections, has laid the foundation to make Pyxant CLS one of the laboratory that observes the most rigorous regulatory operations and the laboratory of choice to send your specialty samples to. The clinical industry, especially the medication management sector, needs a high quality laboratory like Pyxant Labs,” said Jean Pineault, President and COO.
“We decided to extend our services from bioanalytical to support clinical practice because we recognized that our specialized laboratory expertise learned from supporting FDA-regulated drug development programs is uniquely relevant to clinical toxicology assessments. I know that we will make a big impact within this practice area because our long-established scientific, regulatory, and commercial principles far exceed the norm compared to the vast majority of clinical toxicology laboratories,” said Maurice Gaubatz, Founder and CEO.
About Pyxant Labs Inc. – Pyxant Labs is a bioanalytical laboratory offering two distinct laboratory services: Its GLP CRO unit supports drug development for pharmaceutical and biotech companies and its CLIA CLS division assays patient specimens, including urine, oral fluids and blood, for prescribing physicians, clinics, and hospitals, for medication management and clinical diagnostics. Founded in 2000, Pyxant Labs uses state-of-the art mass spectrometry to assay high value samples for regulated industries. Pyxant Labs practices within areas that draw upon the Company’s key strengths: Industry-leading scientific expertise, stringent technical-regulatory compliance, fast turnaround, and exceptional customer service. Pyxant Labs’ greater mission is to improve patient outcomes by offering the most reliable laboratory results, fast.
For more information, contact Kathy Bouard at 719-593-1165 or kbouard(at)pyxant(dot)com